Peptides for the treatment of herpes virus infections
WO2006018431A2
Peptides for the treatment of herpes virus infections
MXPA06014393A
Oligomeric peptides and their use for the treatment of hiv infections.
EP1529535A1
Isolation of a circulating human lipolytic peptide
CA2509423A1
Peptides and their use for the treatment of hiv infections
AU2003274076A1
Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases
AU2003240614A1
A method of inhibiting the emigration of cells from the intravascular compartment into tissues
AU2003210317A1
Novel compound for inhibiting serine proteases and for inhibiting viral infections or viral propagation: rld 8564
Human circulating lekti fragments hf7072, hf7638 and hf14448 and use thereof
DE10160170A1
New antimicrobial peptides, useful clinically and as preservatives for e.g. foods or cosmetics, are derived from bolisin, also related nucleic acids and mimetics
AU2792502A
Human beta-defensin-3
EP1248107A2
Method and device for time-resolved screening
EP1887015A2
Method for extracting and using new human defence agents and biologically active proteins for treating infections and other illnesses
EP1481988A2
Procedure to obtain and use antibiotic peptides for the treatment of infectious diseases
AU6740401A
Novel compounds for the treatment of inflammatory and cardiovascular diseases
AU5631501A
Use of guanylate cyclase-c (gc-c) agonists as insulinotropic factors for treating diabetes type
WO0179539A2
Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep
